 |
Antithrombin III human |
|---|---|
| Trade Name | Antithrombin Iii Human |
| Orphan Indication | Preventing or arresting episodes of thrombosis in patients with congenital AT-III deficiency and/or to prevent the occurrence of thrombosis in patients with AT-III deficiency who have undergone trauma or who are about to undergo surgery or parturition |
| USA Market Approval | USA |
| USA Designation Date | 1986-01-02 00:00:00 |
| Sponsor | American National Red Cross;9312 Old Georgetown Road;Bethesda, Maryland, 20814 |
